Author:
Shahraki Faezeh Niazi,Momtaz Saeideh,Baeeri Maryam,Khayatan Danial,Lashgari Naser-Aldin,Roudsari Nazanin Momeni,Abdollahi Ali Reza,Dehpour Ahmad Reza,Abdolghaffari Amir Hossein
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference43 articles.
1. Yadav, V., et al. 2016. Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets. Translational Research 176: 38–68.
2. Marafini, I., et al. 2019. Inflammatory cytokines: from discoveries to therapies in IBD. Expert Opinion on Biological Therapy 19 (11): 1207–1217.
3. Rohr, M., et al. 2018. Inflammatory diseases of the gut. Journal of Medicinal Food 21 (2): 113–126.
4. Lashgari, N.-A., et al. 2021. Current overview of opioids in progression of inflammatory bowel disease; pharmacological and clinical considerations. Molecular Biology Reports 48 (1): 855–874.
5. Lashgari, N.-A., et al. 2021. Targeting mammalian target of rapamycin: prospects for the treatment of inflammatory bowel diseases. Current Medicinal Chemistry 28 (8): 1605–1624.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献